Despite approval to Zydus Cadila vaccine, kids' inoculation may not start anytime soon

Vaccination for adolescents and kids with serious comorbidities, however, are likely to start in October when sufficient doses of ZyCoV D is available.

Published: 25th August 2021 03:14 AM  |   Last Updated: 25th August 2021 08:33 AM   |  A+A-

A health worker prepares to administer the vaccine for COVID-19 in New Delhi. (Photo | AP)

Express News Service

NEW DELHI:  Despite an approval from the drug regulator to Covid-19 vaccine by Zydus Cadila for the 12-17 age group, apart from adults, vaccination will be available for adolescents and children universally only after adult vaccination is completed. 

Vaccination for adolescents and kids with serious comorbidities, however, are likely to start in October when sufficient doses of ZyCoV D is available.

Talking to this newspaper, N K Arora, chairman of the National Technical Advisory Group on Immunisation said while ZyCoV D has been approved for 12-17 year olds, by the end of this month or early September, Covaxin may also be available for children.

Covaxin by Bharat Biotech is being tested on 2-17 year olds as part of an extended Phase 3 clinical trial that had ended for adults in March-April.

“Our plan is to offer universal vaccination to kids only when all adults are covered as they have a much higher risk of developing serious disease. But we are set to do prioritisation for children with severe underlying conditions,” said Arora. 

He added a panel of doctors who defined the clinical criteria for the 45-59 group in the second phase of vaccination will come up with guidelines for kids’ vaccination. “These guidelines will be released by September end.”

Underlying diseases that may lead to vaccine prioritisation include diabetes, hypertension, cardiovascular diseases, stroke, cancer and chronic respiratory diseases. Experts have said that risk of severe disease due to Covid is far lower in kids. Their vaccination should be considered only when there are vaccines, effective in preventing transmission, are available. 

“None of the available vaccines are capable of preventing transmission. They offer protection from hospitalisation and severe disease. There should be no hurry to vaccinate children,” Chandrakant Lahariya, health systems and vaccine specialist, said earlier.


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp